Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

ALS (ASX:ALQ) Reports FY20 Result

Testing business ALS Ltd (ASX: ALQ) has reported its FY20 result today.

What is ALS?

ALS is one of the world’s largest and most diverse analytical testing services providers.

ALS’ FY20 result

The company announced that revenue rose by 10% to $1.83 billion.

Life Sciences total revenue rose by 13% with organic growth of 5.9%. Commodities revenue grew by 3.5% with organic growth of 0.6%. Industrial revenue grew by 17.6% with organic growth of 15.2%.

The testing business reported underlying net profit from continuing operations of $188.8 million, up 4.3% from last year. Statutory profit was $127.8 million, down $24.8 million due to the effect of one-off gains and impairments.

ALS has recorded a $50 million impairment of goodwill of its Latin American Life Sciences business reflecting enhanced risks, particularly in Brazil and Peru due to socioeconomic issues, COVID-19 and a devaluing of currencies. It also recognised an impairment of $40 million for the industrial division due to COVID-19 impacts and downturn in oil and gas.

Balance sheet and dividend

ALS said it has a “strong” balance sheet with 2.1x leverage, which is well within its covenants with $650 million of liquidity including a $200 million increase of debt facilities.

The business declared a final dividend of 6.1 cents per share, management wanted to be prudent and keep good liquidity.

Time to buy ALS shares?

I don’t know how much growth (or not) ALS will be able to generate in the current environment and over the long term. I prefer industrial shares like Ansell (ASX: ANN) and Fisher & Paykel Healthcare (ASX: FPH).

Disclosure: At the time of writing, Jaz doesn’t own shares in any of the businesses mentioned. 

Are you stuck wondering where to invest right now? Have you got cash 'sitting on the sidelines'? Are you looking for dividend income AND growth but don't know where to start? Rask's expert ASX analyst team has just released a full report, detailing where we'd invest $10,000 right now.

Not only are we offering these 11 investment ideas completely FREE, we've also released an in-depth podcast to go with the report!

So, whether you have $2,000 or $50,000, our brand new analyst report could help transform your watchlist. Right now, you can get the full analyst report emailed to you for FREE by CLICKING HERE NOW or simply entering your email below.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Are you stuck wondering where to invest right now? Have you got cash 'sitting on the sidelines'? Are you looking for dividend income AND growth but don't know where to start? Rask's expert ASX analyst team has just released a full report, detailing where we'd invest $10,000 right now.

Not only are we offering these 11 investment ideas completely FREE, we've also released an in-depth podcast to go with the report!

So, whether you have $2,000 or $50,000, our brand new analyst report could help transform your watchlist. Right now, you can get the full analyst report emailed to you for FREE by CLICKING HERE NOW.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

LIVE ASX Chat - Join in!

Play Video

Keep reading:

Rask Analyst’s $10,000 Hypothetical Portfolio 

Rask Australia’s expert analysts have just released 11 stock & ETF positions they’d buy right now as part of a $10,000 hypothetical portfolio. 

Completely free, this report comes with the exact ticker codes, how much the analysts would invest and a detailed over the company and why we like it. Plus a 60-min podcast! 

Simply enter your email address and we’ll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.